Autopsy report · NCT03920254
TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
Cause of deathFunding or business
“Stopped early due to company decision. Company decision based on interim analysis results in TD-1473-0157.”
Life of this trial
- Registered 1 year 4 months before it started.
- Ran for about 1 year 3 months before it stopped.
- 46 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2, Phase 3
- Sponsor
- Theravance Biopharma
- Sponsor type
- Industry
- Conditions
- Ulcerative Colitis (UC)
- Interventions
- TD-1473 Dose A; TD-1473 Dose B; TD-1473 Dose C
- Participants
- 46
- Sites
- 184
- Countries
- Australia, Bulgaria, Canada, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Poland and more
Trials that died the same way
- Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
“Stopped early due to company decision. Company decision based on analysis results in TD-9855-0169.” - Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
“This study was terminated early due to company decision.” - PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
“The study was terminated early due to company decision.” - Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections
“The study was terminated early after the Interim Analysis due, in part, to issues with the accuracy and completeness of the data collected.” - Adherence to Antidepressant Treatment in Subjects With Depression
“The study was terminated early based on the planned interim analysis that did not meet criteria for continuation.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.